# Lightpath Technologies Inc: Form 10-Q for the period ended Dec 31, 2012

- Company: [Lightpath Technologies Inc](/companies/lpth.md) (CIK 889971)
- Form: 10-Q
- Filed: 2013-02-07
- Accepted by EDGAR: Feb 7, 2013, 08:58 ET
- Period: 2012-12-31
- Accession: 0001387131-13-000298
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/889971/000138713113000298/lpth-10q_123112.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/889971/000138713113000298/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2012-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2012-10-01 to 2012-12-31 | $2.9m | us-gaap:SalesRevenueGoodsNet |
| Revenue | 6 months, 2012-07-01 to 2012-12-31 | $5.8m | us-gaap:SalesRevenueGoodsNet |
| Cost of revenue | 3 months, 2012-10-01 to 2012-12-31 | $1.7m | us-gaap:CostOfGoodsSold |
| Cost of revenue | 6 months, 2012-07-01 to 2012-12-31 | $3.4m | us-gaap:CostOfGoodsSold |
| Gross profit | 3 months, 2012-10-01 to 2012-12-31 | $1.3m | us-gaap:GrossProfit |
| Gross profit | 6 months, 2012-07-01 to 2012-12-31 | $2.4m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months, 2012-10-01 to 2012-12-31 | $1.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months, 2012-07-01 to 2012-12-31 | $2.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2012-10-01 to 2012-12-31 | −$25.1k | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2012-07-01 to 2012-12-31 | −$51.6k | us-gaap:OperatingIncomeLoss |
| Diluted EPS | 3 months, 2012-10-01 to 2012-12-31 | $0.01 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months, 2012-07-01 to 2012-12-31 | $0.02 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2012-10-01 to 2012-12-31 | $0.01 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months, 2012-07-01 to 2012-12-31 | $0.02 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2012-10-01 to 2012-12-31 | 12,728,486 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2012-07-01 to 2012-12-31 | 12,738,595 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months, 2012-07-01 to 2012-12-31 | −$90.3k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months, 2012-07-01 to 2012-12-31 | $488.7k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2012-12-31 | $1.8m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2012-12-31 | $6.5m | us-gaap:AssetsCurrent |
| Total assets | at 2012-12-31 | $8.6m | us-gaap:Assets |
| Current liabilities | at 2012-12-31 | $3.0m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2012-12-31 | $4.1m | us-gaap:Liabilities |
| Shareholders' equity | at 2012-12-31 | $4.5m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 39,362 characters.

*The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by or on behalf of the LightPath Technologies, Inc. (“LightPath”, the “Company” or “we”). All statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and elsewhere in this Quarterly Report on Form 10-Q for the quarter ended December 31, 2012 (the “Quarterly Report”), other than statements of historical facts, which address activities, events or developments that we expect or anticipate will or may occur in the future, including such things as future capital expenditures, growth, product development, sales, business strategy and other similar matters are forward-looking statements. These forward-looking statements are based largely on our current expectations and assumptions and are subject to a number of risks and uncertainties, many of which are beyond our control. Actual results could differ materially from the forward-looking statements set forth herein as a result of a number of factors, including, but not limited to, limited cash resources and the need for additional financing, our dependence on a few key customers, our ability to transition our business into new markets, our ability to increase sales and manage and control costs and other risks described in our reports on file with the Securities and Exchange Commission (“SEC”). In light of these risks and uncertainties, all of the forward-looking statements made herein are qualified by these cautionary statements and there can be no assurance that the actual results or developments anticipated by us will be realized. We undertake no obligation to update or revise any of the forward-looking statements contained herein.*

The discussions of our results as presented in this Quarterly Report include use of the terms “EBITDA” and “gross margin.” EBITDA is discussed below. Gross margin is determined by deducting the cost of sales from operating revenue. Cost of sales includes manufacturing direct and indirect labor, materials, services, fixed costs for rent, utilities and depreciation, and variable overhead. Gross margin should not be considered an alternative to operating income or net income, which are determined in accordance with GAAP. We believe that gross margin, although a non-GAAP financial measure is useful and meaningful to investors as a basis for making investment decisions. It provides investors with information that demonstrates our cost structure and provides funds for our total costs and expenses. We use gross margin in measuring the performance of our business and have historically analyzed and reported gross margin information publicly. Other companies may calculate gross margin in a different manner.

### Overview

*Historical:* We are in the business of manufacturing optical components and higher level assemblies including precision molded glass aspheric optics, isolators, proprietary high performance fiber optic collimators, GRADIUM glass lenses and other optical materials used to produce products that manipulate light. All the products we produce enable lasers and imaging devices to function more effectively.

In November 2005, we formed LightPath Optical Instrumentation (Shanghai) Co., Ltd, (“LPOI”), a wholly-owned manufacturing subsidiary, located in Jiading, People’s Republic of China. The manufacturing operations are housed in a 16,000 square foot facility located in the Jiading Industrial Zone near Shanghai. This plant has increased overall production capacity and enabled us to compete for larger production volumes of optical components and assemblies, and strengthened our partnerships within the Asia/Pacific region.

In 2006, the Company implemented a cash conservation strategy by reducing its operating costs, which included restructuring its manufacturing operations. As we have implemented this new business strategy, the fundamentals of the Company have been improving each year. Although we achieved positive cash flow from operations, we were not profitable during fiscal 2012 or 2011. Cash used by operations was $90,000 for the first six months of fiscal 2013.

*How we operate:* We have continuing sales of two basic types: occasional sales via ad-hoc purchase orders of mostly standard product configurations (our “turns” business); and the more challenging and potentially more rewarding business of custom product development. In this latter type of business, we work with customers in the industrial, medical, defense and communications markets to help them determine optical specifications and even create certain optical designs for them, including complex multi-component designs that we call “engineered assemblies.” That is followed by “sampling” small numbers of the product for their test and evaluation. Thereafter, should the customer conclude that our specification or design is the best solution to their product need, we negotiate and “win” a contract (sometimes called a “design win”) – whether of a “blanket purchase order” type or a supply agreement. The strategy is to create an annuity revenue stream that makes the best use of our production capacity as compared to the turns business, which is unpredictable and uneven. A key business objective is to convert as much of our business to the design win and annuity model as possible. We have several challenges in doing so:

- Maintaining an optical design and new product sampling capability, including a high-quality and responsive optical design engineering staff.
- Customers that incorporate products such as ours into higher volume, commercial applications, continuously work to reduce their expenses, which often leads them to larger or overseas lower-cost suppliers even if sacrificing quality.
- Because of our limited cash resources and cash flow, we may not be able to support the supply requirements needed to service the demands in the market for high-volume, low-cost lenses, without arranging for additional capital expenditures.

Despite these challenges to obtaining more design win business, we nevertheless have been, and believe we can continue to be, successful in procuring this business because of our unique capabilities in optical design engineering. Additionally, we believe that we offer value to some customers as a secondary or backup source of supply in the United States should they be unwilling to commit all of their source of supply of a critical component to a foreign merchant production source. We also continue to have the proprietary GRADIUM lens glass technology to offer to certain laser markets.

*Our key indicators:*

Usually on a weekly basis, management reviews a number of performance indicators. Some of these indicators are qualitative and others are quantitative. These indicators change from time to time as the opportunities and challenges in the business change. They are mostly non-financial indicators such as units of shippable output by major product line, production yield rates by major product line and the output and yield data from significant intermediary manufacturing processes that support the production of the finished shippable product. These indicators can be used to calculate such other related indicators as fully yielded unit production per-shift, which varies by the particular product and our state of automation in production of that product at any given time. Higher unit production per shift means lower unit cost and therefore improved margins or improved ability to compete where desirable for price sensitive customer applications. The data from these reports is used to determine tactical operating actions and changes. We believe that our non-financial production indicators, such as those noted, are proprietary information.

Financial indicators that are usually reviewed at the same time include the major elements of the micro-level business cycle:

- sales backlog;
- EBITDA;
- inventory levels; and
- accounts receivable levels and quality.

These indicators are similarly used to determine tactical operating actions and changes and are discussed in more detail below.

Sales Backlog – We believe that sales growth is our best indicator of success. Our best view into the efficacy of our sales efforts is in our “order book.” Our order book equates to sales “backlog.” Our backlog has a quantitative and a qualitative aspect: quantitatively, our backlog’s prospective dollar value and qualitatively, the percent of the backlog is scheduled by the customer for date-certain delivery. We define our “12-month backlog” as customer orders for delivery within one year which is reasonably likely to be fulfilled, including customer purchase orders and products to be provided under supply contracts if they meet the aforementioned criteria. Generally, a higher 12-month backlog is better for us.

At June 30, 2012, our 12-month backlog was approximately $4.89 million. At December 31, 2012, our 12-month backlog increased by approximately $813,000 to $4.64 million as compared to December 31, 2011. We have seen increased quote activity for our imaging lenses during the six months ended December 31, 2012 compared to the same period last year.

EBITDA- EBITDA is a non-GAAP financial measure used by management, lenders and certain investors as a supplemental measure in the evaluation of some aspects of a corporation's financial position and core operating performance. Investors sometimes use EBITDA as it allows for some level of comparability of profitability trends between those businesses differing as to capital structure and capital intensity by removing the impacts of depreciation, amortization and interest expense. EBITDA also does not include changes in major working capital items such as receivables, inventory and payables, which can also indicate a significant need for, or source of, cash. Since decisions regarding capital investment and financing and changes in working capital components can have a significant impact on cash flow, EBITDA is not a good indicator of a business's cash flows. We use EBITDA for evaluating the relative underlying performance of the Company's core operations and for planning purposes. We calculate EBITDA by adjusting net income (loss) to exclude net interest expense, income tax expense or benefit, depreciation and amortization, thus the term "Earnings Before Interest, Taxes, Depreciation and Amortization" and the acronym "EBITDA."

The following table sets forth EBITDA for the three and six months ended December 31, 2012 and 2011:

*(Unaudited)*

*(Unaudited)*

|  | Three months ended December 31, 2012 | 2011 | Six months ended December 31, 2012 | 2011 |
| --- | ---: | ---: | ---: | ---: |
| Net income (loss) | $140,772 | $(343,299) | $241,993 | $(541,746) |
| Depreciation and amortization | 199,658 | 326,269 | 408,295 | 571,707 |
| Interest expense | 15,500 | 22,566 | 46,806 | 46,786 |
| EBITDA | $355,930 | $5,536 | $697,094 | $76,747 |

Our EBITDA for the six months ended December 31, 2012 increased to approximately $697,000, compared to approximately $77,000 for the six months ended December 31, 2011. The improvement in EBITDA was principally caused by the recognition of net income, instead of net loss, due to higher revenues generating more gross margin, the change in the fair value of our warrant liability with respect to the June 2012 Warrants and royalty income from licensing our GRADIUM product line offset by lower depreciation. For comparison purposes, net income was approximately $242,000 or $0.02 per basic and diluted common share during the first six months of fiscal 2013, compared with the first six months of fiscal 2012, in which we reported a net loss of approximately $542,000 or $0.06 basic and diluted per common share.

Inventory Levels – We manage our inventory levels to minimize investment in working capital but still have the flexibility to meet customer demand to a reasonable degree. While the mix of inventory is an important factor, including adequate safety stocks of long lead-time materials, an important aggregate measure of inventory in all phases of production is the quarter’s ending inventory expressed as a number of days worth of the quarter’s cost of sales, also known as “days cost of sales in inventory,” or “DCSI.” It is calculated by dividing the quarter’s ending inventory by the quarter’s cost of goods sold, multiplied by 365 and divided by 4. Generally, a lower DCSI measure equates to a lesser investment in inventory and therefore more efficient use of capital. During the six months ended December 31, 2012 and 2011, our DCSI was 96 and 89, respectively, compared to 76 for the year ended June 30, 2012. The increase in DCSI from the prior year is a result of our cost reduction program’s success in reducing cost of goods sold while keeping inventory at a similar level.

Accounts Receivable Levels and Quality – Similarly, we manage our accounts receivable to minimize investment in working capital. We measure the quality of receivables by the proportions of the total that are at various increments past due from our normally extended terms, which are generally 30 days. The most important aggregate measure of accounts receivable is the quarter’s ending balance of net accounts receivable expressed as a number of day’s worth of the quarter’s net revenues, also known as “days sales outstanding,” or “DSO.” It is calculated by dividing the quarter’s ending net accounts receivable by the quarter’s net revenues, multiplied by 365 and divided by 4. Generally, a lower DSO measure equates to a lesser investment in accounts receivable, and therefore, more efficient use of capital. For the six months ended December 31, 2012 and 2011, our DSO was 75 and 63, respectively. During the year ended June 30, 2012, our average DSO was 68. Our DSO for the first half of fiscal 2013 was higher than our average DSO for fiscal 2012 due to 53% of the revenue earned during the first six months was from products shipped in December, and therefore, the majority of our total current receivables have not been collected as of December 31, 2012. This compares to 59% of the quarterly revenue for products shipped in December.

Other Key Indicators – Other key indicators include various operating metrics, some of which are qualitative and others are quantitative. These indicators change from time to time as the opportunities and challenges in the business change. They are mostly non-financial indicators such as on time delivery trends, units of shippable output by major product line, production yield rates by major product line and the output and yield data from significant intermediary manufacturing processes that support the production of the finished shippable product. These indicators can be used to calculate such other related indicators as fully-yielded unit production per-shift, which varies by the particular product and our state of automation in production of that product at any given time. Higher unit production per shift means lower unit cost and therefore improved margins or improved ability to compete where desirable for price sensitive customer applications. The data from these reports is used to determine tactical operating actions and changes.

### Liquidity and Capital Resources

In 2006, the Company implemented a cash conservation strategy by reducing its operating costs, which included restructuring its manufacturing operations. However, cash flow and cash management continue to be primary concerns of the Company. The Company has a history of recurring losses from operations and as of December 31, 2012, the Company had an accumulated deficit of approximately $204.4 million. Cash provided by operations was $406,000 for fiscal year 2012 and $95,000 for fiscal year 2011. During the six months ended December 31, 2012, cash used in operations was approximately ($90,000) due to an increase in other receivables related to a large purchase order from Raytheon Vision Systems (“Raytheon”).

At December 31, 2012, we had a book cash balance of approximately $1.78 million. For the six months ended December 31, 2012, cash decreased by approximately $577,000 compared to a decrease of approximately $334,000 for the same period last year. The use of cash in both periods was primarily due to investment capital expenditures for cost reduction equipment used in our anti-reflective coating process, equipment for the infrared product line capacity and tooling for new lenses. On February 4, 2013, the Company had a book cash balance of approximately $1.7 million.

Management developed an operating plan for fiscal 2013 based on anticipated sales growth primarily from precision molded optics, with the emphasis on low-cost, high volume applications, optical assemblies including the redesigned collimator product line and infrared products, and continued implementation of new cost reductions with programs to improve tool life and lower anti-reflective coating costs by coating lenses at our facilities. Management reviews the operating plan on a quarterly basis and makes adjustments as needed. We believe, based on our operating plan and related financial projections, that cash flow from operations will improve in the fourth quarter of fiscal 2013. Our current booking rate of orders combined with recent quote activity and the existing 12-month backlog give us confidence that future cash flow will be sufficient to fund our operations. Our forecast includes an increase in sales in infrared lenses and precision molded optics for imaging and laser tools. We believe growth in mobile internet, the recovery of the Chinese industrial tool market and new product applications bode well for our long term growth. Overall, however, our markets remain weak and somewhat choppy as was indicated by our lower booking rate in the second quarter. To take advantage of emerging opportunities in the marketplace, we have implemented some changes to our sales organization, which we believe will enable us to move more rapidly towards our growth objectives. In addition, we continue to develop new products and keep our product offerings current and relevant to the latest technology as defined by our customers. Our product offerings, which serve a diverse group of end-markets, have found growth opportunities for our core business in precision molded optics and are building a presence in the infrared market.

Factors which could adversely affect cash balances in future quarters include, but are not limited to, a decline in revenue, poor cash collections from our accounts receivables, increased material costs, increased labor costs, planned production efficiency improvements not being realized, the current ongoing economic conditions and increases in other discretionary spending, particularly sales and marketing costs.

To fund future operations, we may seek external debt or equity financing, if it can be obtained in an amount and on terms that are acceptable. We may be required to seek external financing regardless of whether the terms would be acceptable, if our cash flow financial resources are not sufficient to sustain our operations or to pursue our business plan. There is no assurance we will be able to achieve the necessary cash flow from sales growth and gross margin improvements to sustain operations. Factors which could adversely affect cash balances in future quarters include, but are not limited to, a decline in revenue or a lack of anticipated sales growth, increased material costs, increased labor costs, planned production efficiency improvements not being realized, increases in property, casualty, benefit and liability insurance premiums and increases in other discretionary spending, particularly sales and marketing related.

### Sources and Uses of Cash

#### Operating Activities

Our sources of operating cash consist of our limited cash reserves and the cash generated from the collection of receivables after invoicing customers for product shipments. Our uses of operating cash primarily consist of expenditures for materials and services, wages and compensation, employee benefits, rent and utilities. Our plan is to minimize our investment in inventory but still support our sales and forecasted anticipated growth. We manage our accounts payable very carefully. We have taken certain actions to conserve our cash including extending payment terms with certain of our suppliers. We have negotiated payment plans with some key vendors and sometimes work with other vendors to develop payment plans.

#### Investing Activities

Periodically we make expenditures for capital goods. In the first half of fiscal 2013, we had capital expenditures for tooling, equipment to support our tooling operations, as well as purchasing equipment for the infrared product line.

#### Financing Activities

Over the past several fiscal years, our net use of cash has required that we draw down on our cash and cash equivalent balances and periodically raise additional funds through the sale of shares of common stock or, in the case of our August 2008 offering, debentures convertible into shares of our common stock.

If our efforts at reaching positive cash flow and profitability are not successful, we will need to raise additional capital. Should capital not be available to us at reasonable terms, other actions may become necessary in addition to cost control measures and continued efforts to increase sales. These actions may include exploring strategic options for the sale of the Company, the sale of certain product lines, the creation of joint ventures or strategic alliances under which we will pursue business opportunities, the creation of licensing arrangements with respect to our technology, or other alternatives.

We do not currently have any availability for borrowing under equipment leases or other loan facilities and we do not currently have any commitment from any party to provide any other financing to the Company. There can be no assurances that financing will be available to us, or, if available, that the terms of such financing will be acceptable to us. As a result, there is significant risk to us of having limited cash resources with which to continue our operations as currently conducted or to pursue new business opportunities. Either of these outcomes would materially and adversely affect our results of operations, financial performance and stock price.

### Off Balance Sheet Arrangements

We do not engage in any activities involving variable interest entities or off-balance sheet arrangements.

### Results of Operations

### Fiscal Second Quarter: Three months ended December 31, 2012 compared to the three months ended December 31, 2011

### Revenues:

For the quarter ended December 31, 2012, we reported total revenues of $2.92 million compared to $2.67 million for the second quarter of last fiscal year, an increase of 9%. This increase was primarily attributable to increases in sales of custom optics and an increase in our industrial tool products offset by slightly lower sales volumes in our collimator, isolator and GRADIUM® product lines. Growth in sales for the next several quarters is expected to be derived primarily from the precision molded lens product line, with an increase in low cost lenses being sold in Asia and from new business with penetration into imaging applications. Infrared products, now being designed and introduced, are expected to accelerate the Company’s growth more meaningfully beginning in the fourth quarter of fiscal 2013 and continuing in fiscal 2014. Unit shipment volume in precision molded optics increased by 21% in the second quarter of 2013 compared to the same period of the prior fiscal year.

### Cost of Sales:

Our gross margin percentage in the second quarter of fiscal 2013 was 43% compared to 32% for the second quarter of fiscal 2012. Total manufacturing costs of $1.65 million were approximately $178,000 lower in the second quarter of fiscal 2013 compared to the same period of the prior fiscal year. The decrease in manufacturing costs, as compared to the same period of the prior fiscal year, is a result of a decrease of $123,000 in wages, $116,000 in tooling costs and $40,000 in freight costs offset by an increase of $100,000 in costs associated with the Raytheon purchase order.

Unit sales of precision molded optics lenses increased by 21% in the second quarter of fiscal 2013 compared to the same period last year. In the second quarter of fiscal 2013, 36% of our precision molded optic lens units sold were produced with more expensive glass types, compared to 46% in the same period last year. All of the precision molded optics lenses have been redesigned to use lower cost materials; however, some of our customers have continued to purchase the more expense glass type lenses. The increase in sales of the more expensive glass type lenses is the result of the mix change of units sold, with less sales of the lower cost optics that utilizes lower-cost glass materials. The transition from higher-cost glass materials to lower-cost glass materials also causes inefficiencies in our coating process. The lens coating on our higher-cost glass lenses is different from the lens coating on our lower-cost glass lenses and requires separate coating runs, thereby increasing our lens coating costs. Once the transition by our customers to lower-cost glass types is complete, we expect our coating efficiencies to improve and our costs to decrease.

Direct costs, which include material, labor and services, decreased to 23% of revenue in the second quarter of fiscal 2013, as compared to 26% of revenue in the second quarter of fiscal 2012. The decrease in direct costs was primarily due to improved labor productivity and the continued transition to lower cost glass materials.

We have seen improvement in our gross margins for the past three quarters due to the headcount and salary reductions implemented in the fourth quarter of last fiscal year and the increase in sales. As our revenues increase, we expect continued improvements in gross margins as our overhead costs are amortized over a larger revenue base.

### Selling, General and Administrative:

During the second quarter of fiscal 2013, selling, general and administrative (“SG&A”) costs were approximately $1.02 million, compared to $884,000 in the second quarter of fiscal 2012, an increase of approximately $134,000. This increase was due to higher expenses for information technology services, higher investor relations expenses and higher legal expense. We intend to maintain SG&A costs generally at current levels.

### New Product Development:

New product development costs were approximately $264,000 in the second quarter of fiscal 2013 compared to approximately $272,000 in the same period last year, a 3% decrease. We anticipate that these expenses will increase modestly for the remainder of fiscal year 2013 as we invest in the continued development of our infrared product lines.

### Amortization of Intangibles:

Amortization expense from intangibles remained the same at approximately $8,000 per quarter in both the fiscal quarters ended December 31, 2012 and 2011.

### Other Income (Expense):

Interest expense was approximately $15,000 in the second quarter of fiscal 2013 as compared to $22,000 in the second quarter of fiscal 2012. This interest expense resulted from interest on our convertible debentures, at 8% per annum and amortization of debt discount and debt costs.

In the second quarter of fiscal 2013, we recognized a gain of approximately $170,000 related to the change in the fair value of derivative warrants issued in connection with our June 2012 private placement. This fair value will be re-measured each reporting period throughout the five year life of the warrants, or until exercised.

Other income increased by approximately $13,000 to $12,000 in the second quarter of fiscal 2013 compared to a loss of approximately $1,000 in the second quarter of fiscal 2012, due to the foreign currency rate changes.

### Net Income (Loss):

Net income was approximately $141,000 or $0.01 basic and diluted per share during the second quarter of fiscal 2013, compared with the second quarter of fiscal 2012, in which we reported a net loss of approximately $343,000 or $0.04 basic and diluted per share. The approximate $484,000 improvement resulted from higher gross margin due to an increase in sales and lower costs and the change in the fair value of our warrant liability for our June 2012 Warrants. Weighted-average shares outstanding (basic) was 11,801,684 in the second quarter of fiscal 2013 compared to 9,761,129 in the second quarter of fiscal 2012. The increase in weighted-average shares outstanding was primarily due the issuance of shares of common stock related to the the sale of securities in our June 2012 private placement, shares issued related to the payment of interest on convertible debentures and shares issued to our employee stock purchase plan.

### Fiscal First Half: Six months ended December 31, 2012 compared to the six months ended December 31, 2011

### Revenues:

For the six months ended December 31, 2012, we reported total revenues of $5.81 million compared to $5.41 million for the first half of last fiscal year, an increase of 7%. This increase was primarily attributable to an increase in the sales of custom optics, an increase in the sales of our industrial tool products and our entry in the digital projection market offset by slightly lower sales volumes in our collimator, isolator and GRADIUM® product lines. Growth in sales for the next several quarters is expected to be derived primarily from the precision molded lens product line, with an increase in low cost lenses being sold in Asia and from new business with penetration into imaging applications.

### Cost of Sales:

Our gross margin percentage in the first half of fiscal 2013 was 42% compared to 36% for the first half of fiscal 2012. Total manufacturing costs of $3.36 million were approximately $115,000 lower in the first half of fiscal 2013 compared to the same period of the prior fiscal year. This decrease in manufacturing costs, as compared to the same period of the prior fiscal year, is a result of a decrease of $244,000 in wages offset by an increase of $130,000 in indirect costs associated with higher revenues.

Unit sales of precision molded optics lenses increased by 23% in the first half of fiscal 2013 compared to the same period last year. In the first half of fiscal 2013, 41% of our precision molded optic lens units sold were produced with more expensive glass types, compared to 50% in the same period last year. The decrease in sales of the more expensive glass type lenses is the result of the mix change of units sold, with more sales of the lower cost optics that utilizes lower-cost glass materials. The transition from higher-cost glass materials to lower-cost glass materials causes inefficiencies in our coating process. The lens coating on our higher-cost glass lenses is different from the lens coating on our lower-cost glass lenses and requires separate coating runs, thereby increasing our lens coating costs. Once the transition by our customers to lower-cost glass types is complete, we expect our coating efficiencies to improve and our costs to decrease.

Direct costs, which include material, labor and services, decreased to 24% of revenue in the first half of fiscal 2013, as compared to 26% of revenue in the first half of fiscal 2012. The decrease in direct costs was primarily due to improved labor productivity and the continued transition to lower cost glass materials.

We have seen improvement in our gross margins for the past three quarters due to the headcount and salary reductions implemented in the fourth quarter of last fiscal year and the increase in sales. As our revenues increase, we expect continued improvements in gross margins as our overhead costs are amortized over a larger revenue base.

### Selling, General and Administrative:

During the first half of fiscal 2013, SG&A costs were approximately $2.00 million, compared to $1.88 million in the first half of fiscal 2012, an increase of approximately $121,000. This increase was due to higher expenses for information technology services and investor relations. We intend to maintain SG&A costs generally at current levels.

### New Product Development:

New product development costs were approximately $477,000 in the first half of fiscal 2013 compared to approximately $559,000 in the same period last year, a 15% decrease. This decrease was primarily due to a decrease in new product development as our staff focused on the Raytheon purchase order. We anticipate that these expenses will increase modestly for the remainder of fiscal year 2013 as we invest in the continued development of our infrared product line.

### Amortization of Intangibles:

Amortization expense from intangibles remained the same at approximately $16,000 per period in both the fiscal six months ended December 31, 2012 and 2011.

### Other Income (Expense):

Interest expense was approximately $47,000 for both the first half of fiscal 2013 and fiscal 2012. This interest expense resulted from interest on our convertible debentures, at 8% per annum and amortization of debt discount and debt costs.

In the first half of fiscal 2013 we recognized a gain of approximately $265,000 related to the change in the fair value of derivative warrants issued in connection with our June 2012 private placement. This fair value will be re-measured each reporting period throughout the five year life of the warrants, or until exercised.

Other income increased by approximately $41,000 to $75,000 in the first half of fiscal 2013 compared to approximately $34,000 in the first half of fiscal 2012. In the first half of fiscal 2013 we sold a technology license for our GRADIUM product line in Asia for $150,000 of which we recognized other income of $50,000 for reaching the first milestone pursuant to the licensing agreement.

### Net Income (Loss):

Net income was approximately $242,000 or $0.02 basic and diluted per share during the first half of fiscal 2013, compared with the first half of fiscal 2012, in which we reported a net loss of approximately $542,000 or $0.06 basic and diluted per share. The approximate $784,000 improvement resulted from the royality income from licensing the GRADIUM product line, the change in the fair value of our warrant liability for our June 2012 Warrants, a decrease in new product development expenses and higher gross margin due to an increase in sales. Weighted-average shares outstanding (basic) was 11,786,793 in the first half of fiscal 2013 compared to 9,753,618 in the first half of fiscal 2012. The increase in weighted-average shares outstanding was primarily due the issuance of shares of common stock related to the the sale of securities in our June 2012 private placement, shares issued related to the payment of interest on convertible debentures and shares issued related to our employee stock purchase plan.

### Critical Accounting Policies and Estimates:

**Allowance for accounts receivable** is calculated by taking 100% of the total of invoices that are over 90 days past due from due date and 10% of the total of invoices that are over 60 days past due from the due date. Accounts receivable are customer obligations due under normal trade terms. The Company performs continuing credit evaluations of its customers’ financial condition. Recovery of bad debt amounts which were previously written off is recorded as a reduction of bad debt expense in the period the payment is collected. If the Company’s actual collection experience changes, revisions to its allowance may be required. After attempts to collect a receivable have failed, the receivable is written off against the allowance.

**Inventory obsolescence reserve** is calculated by reserving 100% for items that have not been sold in two years or that have not been purchased in two years and 25% for products which we have more than a two year supply, as well as reserving 50% for other items deemed to be slow moving within the last 12 months and reserving 25% for items deemed to have low material usage within the last six months.

**Revenue** is recognized from product sales when products are shipped to the customer, provided that the Company has received a valid purchase order, the price is fixed, title has transferred, collection of the associated receivable is reasonably assured, and there are no remaining significant obligations. Revenues from product development agreements are recognized as milestones are completed in accordance with the terms of the agreements and upon shipment of products, reports or designs to the customer.

The Company recognized and recorded $50,000 in license income in “other income (expense), net” on the accompanying consolidated statement of operations and comprehensive income for the six months ended December 31, 2012. The transaction is being accounted for under the guidance of Accounting Standards Codification (“ASC”) 605-10, Revenue Recognition, in which all fees under the agreement are expected to be collectible in full, the licensing arrangement is exclusive and the term of the license extends beyond the remaining life of the patents.

**Stock based compensation** is measured at grant date, based on the fair value of the award, and is recognized as an expense over the employee’s requisite service period. We estimate the fair value of each stock option as of the date of grant using the Black-Scholes-Merton pricing model. Most options granted under our Amended and Restated Omnibus Incentive Plan vest ratably over two to four years and generally have ten-year contract lives. The volatility rate is based on four-year historical trends in common stock closing prices and the expected term was determined based primarily on historical experience of previously outstanding options. The interest rate used is the U.S. Treasury interest rate for constant maturities. The likelihood of meeting targets for option grants that are performance based are evaluated each quarter. If it is determined that meeting the targets is probable then the compensation expense will be amortized over the remaining vesting period.

**Deferred revenue/ Other receivables** relates to a $1.1 million purchase order from Raytheon that is being recognized into revenue on a percentage of completion basis. The Company is using the “cost-to-cost method” to allow it to measure progress toward completion based on the ratio of costs incurred to date to total estimated costs. The Company recorded in other receivables in the accompanying consolidated balance sheet based the difference between the amounts invoiced on the project and the amount recognized into revenue. As of December 31, 2012, the Company invoiced $743,500 and recognized approximately $1.02 million as revenue, which includes $407,000 that was recognized in the six months ended December 31, 2012. The balance of $279,500 was recorded as other accounts receivable. At December 31, 2012, we had $100,000 in accounts receivable with respect to this purchase order, as reflected in the accompanying consolidated balance sheet. The project is expected to be completed by July 2013.

## Controls and procedures

As filed, 1,008 characters.

Under the supervision and with the participation of our management, including our Chief Executive Officer and our Chief Financial Officer, we evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934 (the "Exchange Act")) as of December 31, 2012, the end of the period covered by this report. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of December 31, 2012 in reporting on a timely basis information required to be disclosed by us in the reports we file or submit under the Exchange Act.

During the fiscal quarter ended December 31, 2012, there was no change in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Filed Feb 7, 2013.
Source: SEC EDGAR, the filing index for accession 0001387131-13-000298. Last ingested by Listed: Nov 11, 2026, 01:28 ET. No prices; not investment advice.
